“ ASX protected against APAP toxicity by inhibiting the depletion of glutathione (GSH) and superoxide dismutase (SOD).”
“ Astaxanthin inhibits the inflammation in APAP induced liver injury.”
“Results: ASX pretreatment before APAP increased the 5‐day survival rate in a dose‐dependent manner and reduced the ALT, AST, hepatic necrosis, reactive oxygen species (ROS) generation, lipid peroxidation (LPO), oxidative stress and pro‐inflammatory factors.”